CancerGuide: What's New in the Kidney Cancer Section

October 3, 2004

I updated my Thalidomide Article to include results from an important randomized study of Low Dose Interferon alone versus Low Dose Interferon Plus Thalidomide. Unfortunately, the results were lousy and like many others, I am increasingly skeptical of Thalidomide, though IL-2 combinations may yet prove out. I also reorganized the article, including references in my standard form and removing the reference pages which used to be below this one.

June 24, 2004

I added notes on the 2004 ASCO meeting. ASCO, The American Society of Clinical Oncology, holds the world's largest general cancer meeting each year. I was there to find out what was new in kidney cancer. I also updated several articles based on what I learned - this article links to those.

June 2, 2004

Reorganized my article on treating the kidney tumor to include more detail based on my attendance at the 2004 American Urological Association Meeting. I expect to hit this one again after some more reading.

April 3, 2004

Completely reorganized the section on Adjuvant Therapy to reflect positive results from an Adjuvant Tumor Vaccine.

March 30, 2004

I added an article on SU11248, a promising new treatment for metastatic RCC.

February 17, 2004

Added a new page on Avastin, a new and somewhat promising anti-angiogenic therapy. I've also gone through most of my articles and corrected typos and made minor changes here and there.

January 2, 2004

Updated my article on the Atzpodien Regimen to include a study I'd inadvertantly left out and to do some minor tuning. The major conclusions remain about the same.
Updated my BAY 43-9006 Article to take account of the closure of the phase II trial and the opening of the patient-unfriendly and ethically unacceptable randomized phase III trial.

December 23, 2003

A Brand New Kidney Cancer Section!

Bigger and Better

This is the first release of a huge expansion of my kidney cancer page. While I've included the material in my old page (heavily modified in most cases), I've expanded every facet of the kidney cancer section, and there are now nearly 40 separate articles covering everything from the well known to the obscure (and possibly lifesaving!). As you look through you'll notice I've also included many more references to the technical literature as well as survival curves directly from the literature.

A Whole New Look

As you've surely noticed if you've been here before, I've completely reorganized the kidney cancer section and added navigation menus. These fast-loading text based menus are hierarchical so that when you open a page, links to the appropriate sub-pages will appear on the menu. The design also makes the most of your display while respecting your choices.

You'll find that the pages will adjust and scale properly within a wide range of win dow sizes and resolutions.
You'll also find that all of the text, including the menus, scales according to your choice of text size (most browsers allow you to make the text size larger or smaller, which is very convenient - especially if you have vision problems - but it only works if the page you are viewing is designed to allow this adjustment).

I am using Cascading Style Sheets and so things may not render properly in very old browsers such as pre 4.0 Netscape and Internet Explorer. They will render in Netscape 4.7 but won't look perfect.

If you have any suggestions for the page design or the pages don't display right for you, please e-mail me at steve@cancerguide.org. If you're having display trouble, let me know what operating system and what web browser and version you're using.

Future Plans

I'm not done with this yet! In addition to updating this material as new information becomes available, some of the things I'm thinking about adding:

Stories: Patient stories on what it's like to actually go through some of the more common treatments including neprectomy, laparoscopic nephrectomy, outpatient and high dose IL-2 and Interferon.
Alternative: Information on alternative therapies.
Follow-Up: Information on follow-up after treatment for localized RCC.
Bone Metastasis: I'm not sure about this but I think there's a chance that this is an area which could be further optimized using information from the treatment of prostate cancer.

Acknowledgments

First, I could not have done this without the time Mike Fischer has given me to do this by funding development of CancerGuide. I have also learned a great deal from members of my KIDNEY-ONC mailing list whose diverse experiences indirectly suffuse this work, and special thanks to PJ Boyle for providing the Nephrectomy Tips article.

Return To Top